This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: The Innovations of Robert Downham
Introduction
Robert Downham is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on 3-substituted 2-amino-indole derivatives. His research has the potential to impact therapeutic applications significantly.
Latest Patents
Robert Downham holds a patent for 3-substituted 2-amino-indole derivatives. The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein Q, X, XX, R, and other variables are defined in the specification. This patent outlines processes for the preparation of such compounds, pharmaceutical compositions containing them, and their use in therapy. He has 1 patent to his name.
Career Highlights
Downham is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda focuses on developing innovative therapies that address unmet medical needs. His expertise in pharmaceutical chemistry has been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Robert has collaborated with esteemed colleagues, including Gregory Barker and Richard John Davenport. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.
Conclusion
Robert Downham's contributions to pharmaceutical innovation exemplify the impact of dedicated research and collaboration in the field. His work continues to pave the way for new therapeutic solutions.